Tetraspanins as therapeutic targets in hematological malignancy: a concise review
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tetraspanins as therapeutic targets in hematological malignancy: a concise review
Authors
Keywords
-
Journal
Frontiers in Physiology
Volume 6, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2015-03-23
DOI
10.3389/fphys.2015.00091
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase 1 study evaluating the safety and tolerability of otlertuzumab, an anti-CD37 mono-specific ADAPTIR therapeutic protein in chronic lymphocytic leukemia
- (2014) J. C. Byrd et al. BLOOD
- Otlertuzumab (TRU-016), an anti-CD37 monospecific ADAPTIR™therapeutic protein, for relapsed or refractory NHL patients
- (2014) John M. Pagel et al. BRITISH JOURNAL OF HAEMATOLOGY
- Function of the tetraspanin molecule CD81 in B and T cells
- (2014) Shoshana Levy IMMUNOLOGIC RESEARCH
- Phase 1b study of otlertuzumab (TRU-016), an anti-CD37 monospecific ADAPTIR™ therapeutic protein, in combination with rituximab and bendamustine in relapsed indolent lymphoma patients
- (2014) Ajay K. Gopal et al. INVESTIGATIONAL NEW DRUGS
- The CD37-targeted antibody–drug conjugate IMGN529 is highly active against human CLL and in a novel CD37 transgenic murine leukemia model
- (2014) K A Beckwith et al. LEUKEMIA
- Down-Regulation of CD9 by Methylation Decreased Bortezomib Sensitivity in Multiple Myeloma
- (2014) Xiaotong Hu et al. PLoS One
- 177Lu-DOTA-HH1, a Novel Anti-CD37 Radio-Immunoconjugate: A Study of Toxicity in Nude Mice
- (2014) Ada H. V. Repetto-Llamazares et al. PLoS One
- Targeted drug delivery and cross-linking induced apoptosis with anti-CD37 based dual-ligand immunoliposomes in B chronic lymphocytic leukemia cells
- (2013) Bo Yu et al. BIOMATERIALS
- A novel anti-CD37 antibody-drug conjugate with multiple anti-tumor mechanisms for the treatment of B-cell malignancies
- (2013) J. Deckert et al. BLOOD
- TSPAN33 is a novel marker of activated and malignant B cells
- (2013) Van Phi Luu et al. CLINICAL IMMUNOLOGY
- Tetraspanin CD37 contributes to the initiation of cellular immunity by promoting dendritic cell migration
- (2013) Kate H. Gartlan et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The Actin and Tetraspanin Networks Organize Receptor Nanoclusters to Regulate B Cell Receptor-Mediated Signaling
- (2013) Pieta K. Mattila et al. IMMUNITY
- Microdomains in the membrane landscape shape antigen-presenting cell function
- (2013) Malou Zuidscherwoude et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Glycovariant anti-CD37 monospecific protein therapeutic exhibits enhanced effector cell-mediated cytotoxicity against chronic and acute B cell malignancies
- (2013) Sarwish Rafiq et al. mAbs
- Tetraspanin CD37 Directly Mediates Transduction of Survival and Apoptotic Signals
- (2012) Rosa Lapalombella et al. CANCER CELL
- The TspanC8 Subgroup of Tetraspanins Interacts with A Disintegrin and Metalloprotease 10 (ADAM10) and Regulates Its Maturation and Cell Surface Expression
- (2012) Elizabeth J. Haining et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Gene Expression Commons: An Open Platform for Absolute Gene Expression Profiling
- (2012) Jun Seita et al. PLoS One
- The Tetraspanin CD37 Orchestrates the 4 1 Integrin-Akt Signaling Axis and Supports Long-Lived Plasma Cell Survival
- (2012) A. B. van Spriel et al. Science Signaling
- A novel Fc-engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B-cell malignancies
- (2011) K.-H. Heider et al. BLOOD
- Tetraspanins in the immune response against cancer
- (2011) Sharon Veenbergen et al. IMMUNOLOGY LETTERS
- Action of novel CD37 antibodies on chronic lymphocytic leukemia cells
- (2011) G Krause et al. LEUKEMIA
- The tetraspanin CD9 regulates migration, adhesion, and homing of human cord blood CD34+ hematopoietic stem and progenitor cells
- (2010) K. T. Leung et al. BLOOD
- A genome-wide linkage scan reveals CD53 as an important regulator of innate TNF-α levels
- (2010) Steffan D Bos et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Structure-Function Analysis of Tetraspanin CD151 Reveals Distinct Requirements for Tumor Cell Behaviors Mediated by α3β1versusα6β4 Integrin
- (2010) Shannin Zevian et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Complementary Role for the Tetraspanins CD37 and Tssc6 in Cellular Immunity
- (2010) K. H. Gartlan et al. JOURNAL OF IMMUNOLOGY
- Tetraspanins in human epithelial malignancies
- (2010) Hanna M Romanska et al. JOURNAL OF PATHOLOGY
- Lateral organization of membrane proteins: tetraspanins spin their web
- (2009) Stéphanie Charrin et al. BIOCHEMICAL JOURNAL
- A novel therapeutic strategy with anti-CD9 antibody in gastric cancers
- (2009) Taisei Nakamoto et al. JOURNAL OF GASTROENTEROLOGY
- The Tetraspanin Protein CD37 Regulates IgA Responses and Anti-Fungal Immunity
- (2009) Annemiek B. van Spriel et al. PLoS Pathogens
- The Inhibition of Tumor Cell Intravasation and Subsequent Metastasis via Regulation of In Vivo Tumor Cell Motility by the Tetraspanin CD151
- (2008) Andries Zijlstra et al. CANCER CELL
- Epigenetic Silencing of the Tetraspanin CD9 during Disease Progression in Multiple Myeloma Cells and Correlation with Survival
- (2008) E. De Bruyne et al. CLINICAL CANCER RESEARCH
- Tetraspanins CD37 and CD151 differentially regulate Ag presentation and T-cell co-stimulation by DC
- (2008) Kuo-Ching Sheng et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started